Issue 2/1999
Content (11 Articles)
Activity of Doxorubicin Covalently Bound to a Novel Human Serum Albumin Microcapsule
Martin Eatock, Nicola Church, Roy Harris, Wilson Angerson, Colin McArdle, Ray French, Chris Twelves
Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy
Charles J. Dimitroff, Wayne Klohs, Amarnath Sharma, Paula Pera, Denise Driscoll, Jean Veith, Randall Steinkampf, Mel Schroeder, Sylvester Klutchko, Adam Sumlin, Barbara Henderson, Thomas J. Dougherty, Ralph J. Bernacki
RAS Inhibitors in Hematologic Cancers: Biologic Considerations and Clinical Applications
Darrin M. Beaupre, Razelle Kurzrock
A New Statistical Method for Dose-Finding Based on Efficacy and Toxicity in Early Phase Clinical Trials
Peter F. Thall, Elihu H. Estey, Hsi-Guang Sung
Phase II Trial of Menogaril in Non-Hodgkin's Lymphomas: a Southwest Oncology Group Trial
Dennis F. Moore Jr., Thomas D. Brown, Michael LeBlanc, Steve Dahlberg, Thomas P. Miller, Suzanne McClure, Richard I. Fisher
A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer
Robert S. Witte, Stuart Lipsitz, Thomas L. Goodman, Robert F. Asbury, George Wilding, Charles M. Strnad, Thomas J. Smith, Daniel G. Haller
Phase II Clinical Trial of Didemnin B in Patients with Recurrent or Refractory Anaplastic Astrocytoma or Glioblastoma Multiforme (NSC 325319)
Abraham Mittelman, Hoo G. Chun, Carmelo Puccio, Nancy Coombe, Thomas Lansen, Tauseef Ahmed
Phase II Trial of Suramin in Patients with Metastatic Renal Cell Carcinoma
Robert Dreicer, David C. Smith, Richard D. Williams, William A. See
Phase II Study of Paclitaxel in Combination with Mitoxantrone and Ifosfamide/Mesna for Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma after Failure to Cytarabine/Cisplatin Combination
Jorge E. Romaguera, M. Alma Rodriguez, Fredrick B. Hagemeister, Peter McLaughlin, Jose Rodriguez, Alejandro Preti, Anas Younes, Andreas H. Sarris, Fernando Cabanillas